The BioHub: The Top Voices in Biotech – Détails, épisodes et analyse
Détails du podcast
Informations techniques et générales issues du flux RSS du podcast.

The BioHub: The Top Voices in Biotech
Max Brennan - Biotech HeadHunter
Fréquence : 1 épisode/7j. Total Éps: 85

Classements récents
Dernières positions dans les classements Apple Podcasts et Spotify.
Apple Podcasts
🇺🇸 États-Unis - lifeSciences
14/08/2025#96🇩🇪 Allemagne - lifeSciences
13/08/2025#83🇫🇷 France - lifeSciences
13/08/2025#99🇫🇷 France - lifeSciences
12/08/2025#82🇫🇷 France - lifeSciences
11/08/2025#79🇫🇷 France - lifeSciences
10/08/2025#73🇫🇷 France - lifeSciences
09/08/2025#63🇫🇷 France - lifeSciences
08/08/2025#54🇫🇷 France - lifeSciences
07/08/2025#48🇺🇸 États-Unis - lifeSciences
06/08/2025#69
Spotify
Aucun classement récent disponible
Liens partagés entre épisodes et podcasts
Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.
See allQualité et score du flux RSS
Évaluation technique de la qualité et de la structure du flux RSS.
See allScore global : 22%
Historique des publications
Répartition mensuelle des publications d'épisodes au fil des années.
Episode 43 - Gwen Acton, Vivo Group
Saison 2 · Épisode 43
mercredi 2 avril 2025 • Durée 34:08
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
I’m joined by Gwen Acton, CEO of Vivo Group and an expert in leadership development for scientists, engineers, and biotech professionals.
Gwen has had a fascinating career—she earned a PhD from MIT, was a faculty member at Harvard, ran operations at the Whitehead Institute during the Human Genome Project, and has helped thousands of technical experts become stronger leaders.
Now, she’s adding “author” to her resume with a brand-new book on leadership, and today, we’re diving into why leadership is so crucial in biotech, how it’s evolved, and what inspired her to write it.
Enjoy and stay tuned
Episode 42 - David De Graaf, CEO of Reverb Therapeutics
Saison 2 · Épisode 42
mercredi 2 avril 2025 • Durée 27:26
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.Today we're joined by David De Graaf, CEO of Co-Founder of Reverb TherapeuticsDavid has an incredible background, with positions at companies such as AstraZeneca, Pfizer, Apple Tree Partners & Boehringer Ingelheim as well being at the helm of multiple successful biotechs. In this episode, we dive into his journey, building out seed stage biotech's from scratch as well as the Canadian Biotech scene
Episode 35 - David Esposito, CEO ONL Therapeutics
mardi 11 février 2025 • Durée 22:50
Thank you for tuning into another episode of Bio Hub! Today, we have the privilege of hosting David Esposito, a seasoned leader in the biotech industry and the CEO of ONL Therapeutics. David's experience is vast, spanning over two decades in leadership roles across the biotech landscape. He has previously served as President and CEO of Armune Biosciences, VP Commercial Operations at Thermo Fisher, and Executive Director Commercial Strategy at Merck.
JP Morgan Glen Gowers
mardi 11 février 2025 • Durée 05:14
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have Glen Gowers, CEO and co-Founder of Basecamp Research.
Listen to hear how they've been doing.
JP Morgan Simrit Parmar
mardi 11 février 2025 • Durée 15:34
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have Simrit Parmar, Founder of Cellenkos.
Listen to hear how they've been doing.
JP Morgan Angelos Stergiou
mardi 11 février 2025 • Durée 16:15
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have Angelos Stergiou, CEO of Sellas Life Sciences
Listen to hear how they've been doing.
JP Morgan Michael Parini
mardi 11 février 2025 • Durée 06:43
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have Michael Parini, CEO of Spur Therapeutics.
Listen to hear how they've been doing.
JP Morgan Yang Liu
mardi 11 février 2025 • Durée 06:20
Our little spin off of our time at JPM!
Big announcements and exclusives! Here we have Yang Liu, CEO & CSO of OncoC4.
Listen to hear how they've been doing.
JP Morgan Adrian Rawcliffe
mardi 11 février 2025 • Durée 15:24
The first of our little spin off and time at JPM!
Big announcements and exclusives! Here we have Adrian Rawcliffe, CEO of Adaptimmune.
Listen to hear how they've been doing.
Episode 34 - Michael Castagna, CEO Mannkind
Saison 2 · Épisode 34
mardi 11 février 2025 • Durée 35:47
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
We have a special guest—Michael Castagna, CEO of MannKind Corporation. Michael has over 25 years of experience in marketing, sales, and business development across both Fortune 500 companies and biotech startups.
Under his leadership, MannKind has grown into a major player in the field of endocrine and orphan lung diseases, bringing innovative therapies like Afrezza®, the only inhaled ultra-rapid-acting insulin, to market.
In this episode, Michael shares his journey, the challenges and triumphs of leading MannKind, and the future of the company’s groundbreaking technologies.
We also dive deep into his passion for turning around struggling companies and the lessons he’s learned from navigating the biotech landscape.
Enjoy and Stay Tuned.